srb-5 Antibody

What is SRB-5 and how does it relate to the Mediator complex?

SRB-5 is synonymous with MED18, a critical component of the Mediator complex involved in transcription regulation. This 208-amino acid protein functions as an essential factor for activating gene transcription and plays crucial roles in development, differentiation, and cell cycle control. The MED18 protein (SRB5) serves as a bridge between gene-specific transcription factors and RNA polymerase II, making it vital for proper gene expression regulation .

What are the primary applications of SRB-5 antibody in molecular biology research?

SRB-5 antibodies are primarily utilized in Western blot (WB) and ELISA applications to detect and quantify MED18 protein in various experimental settings. These antibodies enable researchers to investigate transcriptional regulation mechanisms, Mediator complex assembly and function, and gene expression patterns in different cell types and experimental conditions. The specificity of anti-SRB-5 antibodies makes them valuable tools for studying fundamental transcriptional processes in both normal and pathological states .

What sample types can be effectively analyzed using SRB-5 antibody?

Based on validation studies, SRB-5 (MED18) antibodies demonstrate strong reactivity with human and mouse samples. Specifically, positive detection has been confirmed in human cell lines like HT-29 and Jurkat, as well as mouse liver and thymus tissues. This cross-species reactivity makes SRB-5 antibodies particularly valuable for comparative studies between human and murine models investigating transcriptional regulation mechanisms .

What are the optimal conditions for using SRB-5 antibody in Western blot applications?

For optimal Western blot results with SRB-5 antibody, a dilution range of 1:500 to 1:1000 is recommended. The antibody is typically used with standard Western blot protocols, including proper sample preparation, SDS-PAGE separation, and transfer to appropriate membranes. For enhanced specificity, researchers should optimize blocking conditions (typically 5% non-fat milk or BSA) and include appropriate positive controls such as lysates from HT-29 or Jurkat cell lines, which are known to express detectable levels of MED18/SRB-5 .

How can researchers confirm the specificity of their SRB-5 antibody results?

Confirming specificity requires multiple validation approaches:

• Positive controls: Use known MED18-expressing samples like HT-29 or Jurkat cell lysates

• Molecular weight verification: Confirm detection at the expected ~28 kDa band

• Peptide competition assay: Pre-incubate antibody with immunizing peptide to block specific binding

• Secondary antibody-only control: Verify absence of non-specific binding

• siRNA knockdown: Demonstrate reduced signal following MED18 knockdown

• Comparison with alternative antibodies: Test multiple antibodies targeting different MED18 epitopes

What considerations should be made when selecting between polyclonal and monoclonal SRB-5 antibodies?

The selection between polyclonal and monoclonal SRB-5 antibodies depends on research objectives:

Each type offers distinct benefits, with polyclonal antibodies providing broader detection capability while monoclonal antibodies offer greater consistency in long-term studies .

How can SRB-5 antibody be utilized to study Mediator complex dynamics?

For investigating Mediator complex dynamics, researchers can employ SRB-5 antibody in co-immunoprecipitation (Co-IP) experiments to identify protein-protein interactions within the complex. This approach allows for the identification of direct binding partners and complex assembly mechanisms. Additionally, combining SRB-5 antibody with crosslinking techniques enables the capture of transient interactions within the Mediator complex. For spatial organization studies, researchers can employ proximity ligation assays (PLA) using SRB-5 antibody alongside antibodies against other Mediator components to visualize their spatial relationships within the nucleus .

What strategies can be employed for using SRB-5 antibody in ChIP experiments?

For chromatin immunoprecipitation (ChIP) applications using SRB-5 antibody, researchers should:

• Optimize crosslinking conditions (typically 1% formaldehyde for 10 minutes)

• Ensure adequate chromatin fragmentation (200-500 bp fragments)

• Use appropriate antibody concentrations (typically 2-5 μg per ChIP reaction)

• Include IgG controls to assess non-specific binding

• Validate enrichment at known MED18-bound promoters

• Consider dual crosslinking with DSG followed by formaldehyde for improved capture of protein-protein interactions

• For difficult samples, employ a sequential ChIP approach using antibodies against different Mediator components

How does the conservation of SRB-5/MED18 impact experimental design across species?

The amino acid sequence of MED18 shows high conservation across mammalian species, with significant similarity even in more distant organisms. When designing cross-species experiments, researchers should:

• Verify epitope conservation through sequence alignment analysis

• Validate antibody reactivity in each target species through Western blot

• Adjust experimental conditions (antibody concentration, incubation time) for each species

• Consider species-specific positive controls

• Be aware that conservation may vary at post-translational modification sites, potentially affecting antibody recognition in functional studies

What are common challenges when using SRB-5 antibody in immunofluorescence and how can they be addressed?

Common challenges in immunofluorescence experiments with SRB-5 antibody include:

Optimizing each step in the protocol and including appropriate controls are essential for reliable results .

How should researchers interpret discrepancies between SRB-5 antibody results and mRNA expression data?

When faced with discrepancies between protein detection using SRB-5 antibody and mRNA expression data, researchers should consider:

• Post-transcriptional regulation mechanisms that may affect protein abundance

• Protein stability and turnover rates that differ from mRNA half-life

• Epitope masking due to protein interactions or conformational changes

• Technical variations in antibody sensitivity versus mRNA detection methods

• Subcellular localization differences that might affect detection

• Alternative splicing producing protein isoforms that may not be recognized by the antibody

Resolving such discrepancies requires complementary approaches such as alternative antibodies, mass spectrometry validation, or reporter gene assays .

How is SRB-5/MED18 antibody being utilized in disease-related research?

Recent research has implicated the Mediator complex, including MED18/SRB-5, in various disease processes. Researchers are using SRB-5 antibodies to:

• Investigate MED18's role in cancer progression through altered transcriptional programs

• Study neurodevelopmental disorders linked to transcriptional dysregulation

• Examine metabolic disease mechanisms involving disrupted nuclear receptor signaling

• Analyze MED18's contribution to inflammatory response gene regulation

• Explore developmental disorders caused by Mediator complex dysfunction

These investigations typically combine SRB-5 antibody-based protein detection with functional assays to determine the mechanistic contributions of MED18 to disease pathogenesis .

What emerging technologies are enhancing SRB-5/MED18 research beyond traditional antibody applications?

Cutting-edge approaches enhancing SRB-5/MED18 research include:

• CUT&RUN (Cleavage Under Targets and Release Using Nuclease): Offering higher signal-to-noise ratio than traditional ChIP for mapping MED18 genomic occupancy

• Proximity labeling techniques (BioID, APEX): Identifying novel MED18 interaction partners in living cells

• Single-molecule imaging: Visualizing MED18 dynamics within individual transcription complexes

• CRISPR-mediated tagging: Creating endogenously tagged MED18 for live-cell tracking

• Cryo-EM structural analysis: Determining MED18's position and interactions within the Mediator complex architecture

• Integrative multi-omics approaches: Correlating MED18 binding with epigenetic modifications and transcriptional outputs

How does the research on SRB-5/MED18 relate to studies of other transcriptional regulatory systems?

SRB-5/MED18 research intersects with broader transcriptional regulatory systems in several ways:

• Provides insights into how gene-specific activators communicate with the general transcription machinery

• Reveals mechanisms of transcriptional coordination during development and differentiation

• Illuminates how cells integrate multiple signaling inputs at the level of gene expression

• Demonstrates principles of modular assembly in large nuclear complexes

• Contributes to understanding evolutionary conservation of transcriptional regulation

Researchers are increasingly using SRB-5 antibodies alongside tools targeting other regulatory factors to construct comprehensive models of transcriptional control networks. This integrated approach allows for a more complete understanding of how genetic information is selectively expressed across different cell types and conditions .